The approximately 50-fold higher tracer uptake of the affibody in the ccRCC model compared with the head and neck carcinoma models might be due to the fact that the level of CAIX expression in the SCCNij153 model is appreciably lower than the level of CAIX expression in SK-RC-52. The gene discussed is CA9; the disease is head and neck carcinoma.